Shares of e-therapeutics plc (ETX.L) (LON:ETX) gapped down before the market opened on Thursday . The stock had previously closed at $19.20, but opened at $18.50. e-therapeutics plc (ETX.L) shares last traded at $19.20, with a volume of 245,654 shares changing hands.
The company has a market capitalization of £80.79 million and a PE ratio of -19.20. The company has a current ratio of 36.70, a quick ratio of 35.91 and a debt-to-equity ratio of 0.30. The business’s fifty day moving average is GBX 16.26 and its two-hundred day moving average is GBX 14.53.
In other news, insider Trevor Mervyn Jones bought 33,417 shares of e-therapeutics plc (ETX.L) stock in a transaction on Monday, January 4th. The shares were bought at an average cost of GBX 16 ($0.21) per share, with a total value of £5,346.72 ($6,985.52).
e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom. It is developing two NDD-derived immuno-oncology programs, including tryptophan catabolism and immune checkpoint modulation. The company, through its subsidiary, Searchbolt Limited, develops search engine technology.
Featured Article: What is intrinsic value?
Receive News & Ratings for e-therapeutics plc (ETX.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics plc (ETX.L) and related companies with MarketBeat.com's FREE daily email newsletter.